Section for Biomedical Physics, Department of Radiation Oncology, University Hospital and Medical Faculty, Eberhard Karls University Tübingen, Tübingen, Germany.
German Cancer Consortium (DKTK), Partner Site Tübingen; and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Strahlenther Onkol. 2019 Apr;195(4):327-334. doi: 10.1007/s00066-018-1386-z. Epub 2018 Oct 25.
To compare radiotherapy treatments plans in esophageal cancer calculated for a high-field magnetic resonance imaging (MRI)-linac with plans for a conventional linac.
Ten patients with esophageal squamous cell carcinomas were re-planned retrospectively using the research version of Monaco (V 5.19.03, Elekta AB, Stockholm, Sweden). Intensity modulated radiotherapy (IMRT) plans with a nine-field step-and-shoot technique and two-arc volumetric modulated arc therapy (VMAT) plans were created for the Elekta MRI-linac and a conventional linac, respectively. The prescribed dose was 60 Gy to the primary tumor (PTV) and 50 Gy to elective volumes (PTV). Plans were optimized for optimal coverage of the 60 Gy volume and compared using dose-volume histogram parameters.
All calculated treatment plans met predefined criteria for target volume coverage and organs at risk dose both for MRI-linac and conventional linac. Plans for the MRI-linac had a lower number of segments and monitor units. No significant differences between both plans were seen in terms of V of the lungs and V of the heart with slightly higher mean doses to the heart (14.0 Gy vs. 12.5 Gy) and lungs (12.8 Gy vs. 12.2 Gy).
Applying conventional target volume and margin concepts as well as dose-fractionation prescription reveals clinically acceptable dose distributions using hybrid MRI-linac in its current configuration compared to standard IMRT/VMAT. This represents an important prerequisite for future studies to investigate the clinical benefit of MRI-guided radiotherapy exploiting the conceptional advantages such as reduced margins, plan adaptation and biological individualization and hypofractionation.
比较使用高磁场磁共振成像(MRI)-直线加速器计算的食管癌放射治疗计划与常规直线加速器的计划。
对 10 例食管鳞状细胞癌患者进行回顾性再计划,使用 Monaco 研究版(V5.19.03,瑞典 Elekta AB)。为 Elekta MRI-直线加速器和常规直线加速器分别创建了九野步进和射击技术的强度调制放疗(IMRT)计划和两弧容积调制弧形治疗(VMAT)计划。规定剂量为 60Gy 至原发肿瘤(PTV)和 50Gy 至选择性体积(PTV)。计划针对 60Gy 体积的最佳覆盖进行了优化,并使用剂量-体积直方图参数进行了比较。
所有计算的治疗计划均满足 MRI-直线加速器和常规直线加速器的目标体积覆盖和危险器官剂量的预设标准。MRI-直线加速器的计划具有较低的段数和监测单位数。在肺 V 和心脏 V 方面,两种计划之间没有明显差异,心脏(14.0Gy 与 12.5Gy)和肺部(12.8Gy 与 12.2Gy)的平均剂量略高。
在当前配置下,使用混合式 MRI-直线加速器,应用常规的靶区和边界概念以及剂量分割处方,可以获得与标准 IMRT/VMAT 相比具有临床可接受的剂量分布。这代表了未来研究的重要前提,以调查利用概念优势(如减少边界、计划适应和生物学个体化以及适形分割)的 MRI 引导放疗的临床获益。